Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 5
1963 4
1964 3
1965 6
1966 6
1967 5
1968 4
1969 5
1970 1
1971 2
1973 3
1974 2
1975 2
1976 5
1977 4
1978 4
1979 6
1980 6
1981 2
1982 7
1983 9
1984 8
1985 10
1986 18
1987 8
1988 15
1989 12
1990 6
1991 17
1992 16
1993 31
1994 21
1995 25
1996 24
1997 24
1998 17
1999 30
2000 25
2001 26
2002 29
2003 26
2004 29
2005 34
2006 24
2007 35
2008 31
2009 30
2010 40
2011 65
2012 64
2013 42
2014 51
2015 39
2016 36
2017 59
2018 43
2019 54
2020 55
2021 23
Text availability
Article attribute
Article type
Publication date

Search Results

1,163 results
Results by year
Filters applied: . Clear all
Page 1
Novel cancer therapy targeting microbiome.
Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y. Nagano T, et al. Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190864 Free PMC article. Review.
Parental-to-embryo switch of chromosome organization in early embryogenesis.
Collombet S, Ranisavljevic N, Nagano T, Varnai C, Shisode T, Leung W, Piolot T, Galupa R, Borensztein M, Servant N, Fraser P, Ancelin K, Heard E. Collombet S, et al. Among authors: nagano t. Nature. 2020 Apr;580(7801):142-146. doi: 10.1038/s41586-020-2125-z. Epub 2020 Mar 25. Nature. 2020. PMID: 32238933
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N; J-Land 3S Study Group. Kakihana Y, et al. Among authors: nagano t. Lancet Respir Med. 2020 Sep;8(9):863-872. doi: 10.1016/S2213-2600(20)30037-0. Epub 2020 Mar 31. Lancet Respir Med. 2020. PMID: 32243865 Clinical Trial.
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, Yamaguchi M, Tanabe H, Kimura-Someya T, Shirouzu M, Ogata H, Tokuyama K, Ueki K, Nagano T, Tanaka A, Yokoyama S, Kadowaki T. Okada-Iwabu M, et al. Among authors: nagano t. Nature. 2013 Nov 28;503(7477):493-9. doi: 10.1038/nature12656. Epub 2013 Oct 30. Nature. 2013. PMID: 24172895
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T, Ichimura Y, Taguchi K, Suzuki T, Mizushima T, Takagi K, Hirose Y, Nagahashi M, Iso T, Fukutomi T, Ohishi M, Endo K, Uemura T, Nishito Y, Okuda S, Obata M, Kouno T, Imamura R, Tada Y, Obata R, Yasuda D, Takahashi K, Fujimura T, Pi J, Lee MS, Ueno T, Ohe T, Mashino T, Wakai T, Kojima H, Okabe T, Nagano T, Motohashi H, Waguri S, Soga T, Yamamoto M, Tanaka K, Komatsu M. Saito T, et al. Among authors: nagano t. Nat Commun. 2016 Jun 27;7:12030. doi: 10.1038/ncomms12030. Nat Commun. 2016. PMID: 27345495 Free PMC article.
1,163 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page